SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001683168-23-006072
Filing Date
2023-08-25
Accepted
2023-08-25 15:16:28
Documents
1
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY sunshine_pre14a.htm PRE 14A 83739
  Complete submission text file 0001683168-23-006072.txt   85017
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41282 | Film No.: 231207701
SIC: 2834 Pharmaceutical Preparations